Name Net reduced
positions
Reduced positions Increased positions Return since
31 Dec ‘22
2176
3 32 29 31.1%
2177
3 21 18 85.7%
2178
3 4 1 99.6%
CLLS
2179
Cellectis
CLLS
$409M
3 12 9 94.3%
2180
3 15 12 85.5%
2181
3 3 0 50.5%
2182
3 34 31 52.7%
2183
3 3 0 82.7%
2184
3 15 12 47.8%
2185
3 30 27 6.05%
IPHA
2186
Innate Pharma
IPHA
$165M
3 5 2 52.8%
2187
3 12 9 22.9%
2188
3 5 2 15.3%
2189
3 12 9 48.9%
2190
3 19 16 5.81%
2191
3 6 3 10.9%
2192
3 18 15 90.6%
2193
3 37 34 7.09%
2194
3 5 2 1.15%
2195
3 14 11 122%
2196
3 44 41 17%
2197
3 4 1 167%
2198
3 12 9 33.1%
2199
3 110 107 59.2%
2200
3 164 161 79.4%